Epithelial Na Channels (ENaC) are responsible for the apical entry of Na ϩ in a number of different epithelia including the renal connecting tubule and cortical collecting duct. Proteolytic cleavage of ␥-ENaC by serine proteases, including trypsin, furin, elastase, and prostasin, has been shown to increase channel activity. Here, we investigate the ability of another serine protease, tissue kallikrein, to regulate ENaC. We show that excretion of tissue kallikrein, which is secreted into the lumen of the connecting tubule, is stimulated following 5 days of a high-K ϩ or low-Na ϩ diet in rats. Urinary proteins reconstituted in a low-Na buffer activated amiloride-sensitive currents (I Na) in ENaC-expressing oocytes, suggesting an endogenous urinary protease can activate ENaC. We next tested whether tissue kallikrein can directly cleave and activate ENaC. When rat ENaC-expressing oocytes were exposed to purified tissue kallikrein from rat urine (RTK), ENaC currents increased threefold in both the presence and absence of a soybean trypsin inhibitor (SBTI). RTK and trypsin both decreased the apparent molecular mass of cleaved cell-surface ␥-ENaC, while immunodepleted RTK produced no shift in apparent molecular mass, demonstrating the specificity of the tissue kallikrein. A decreased effect of RTK on Xenopus ENaC, which has variations in the putative prostasin cleavage sites in ␥-ENaC, suggests these sites are important in RTK activation of ENaC. Mutating the prostasin site in mouse ␥-ENaC (␥RKRK186QQQQ) abolished ENaC activation and cleavage by RTK while wild-type mouse ENaC was activated and cleaved similar to that of the rat. We conclude that tissue kallikrein can be a physiologically relevant regulator of ENaC activity.
aldosterone; Na depletion; prostasin; protease THE EPITHELIAL SODIUM CHANNEL (ENaC) is responsible for sodium transport across the apical membrane of a number of transporting epithelia. In the connecting tubule and collecting duct of the nephron, ENaC constitutes the final pathway of sodium reabsorption and thus is critical in maintaining total body sodium homeostasis (9) . To accomplish this regulation of sodium reabsorption, ENaC translation, cellsurface expression time, and open probability (P o ) are all tightly regulated (20, 27) . In recent years, ENaC regulation by proteolytic cleavage has been heavily studied. The endocytic protease furin has been shown to cleave the extracellular domain of the ␣-subunit of ENaC at two sites and the extracellular domain of the ␥-subunit of ENaC at one site (25, 26, 51) . In addition, a host of extracellular serine proteases are capable of cleaving the extracellular domain of ␥-ENaC subunit at one or more sites to complete the proteolytic processing of the channel. This proteolytic processing of ENaC increases the P o of ENaC from a closed "near-silent" state (8, 13) . Proper coordination of this process depends on the activity, localization, and expression of extracellular serine proteases involved in ␥-subunit cleavage. Cleavage of the ␥-subunit plays a dominant role in activating ENaC (10) . Thus the regulation of extracellular serine proteases and their ability to activate ␥-ENaC are potentially important aspects of Na homeostasis.
The set of extracellular serine proteases found to activate ENaC includes both soluble (trypsin, chymotrypsin, elastase, and plasmin) and membrane-anchored [prostasin and other channel-activating proteases (CAPs)] enzymes (49) . Both subsets of extracellular proteases presumably process ␥-ENaC localized at the cell surface. Proteolytic cleavage of ENaC was initially found to be a functional modulator of channel activity under physiological conditions in 1980, when aprotinin, a nonselective serine protease inhibitor, was shown to decrease amiloride-sensitive short-circuit currents when applied to toad bladder epithelium (40, 41) . These findings were later confirmed in A6 (Xenopus laevis kidney) cells (2) . Independently, a complementation assay used to search for proteins that increased ENaC currents identified prostasin (CAP1) (58) . Later, other members of the CAP family were found to activate ENaC through cleavage of the ␥-subunit as well as other cleavage-independent mechanisms (19, 48, 58, 59) . Proteolytic cleavage of ENaC by extracellular proteases has also been demonstrated under pathological conditions in a number of epithelia. The amount of serine-protease neutrophil elastase is dramatically increased in the lungs of cystic fibrosis (CF) patients and may be partially responsible for the increased ENaC activity that leads to decreased mucociliary clearance (3, 7, 23) . In rat models of nephrotic syndrome characterized by sodium retention and fluid overload, plasmin is filtered by the glomerulus and reaches the distal nephron, where it activates ENaC by cleaving ␥-ENaC either directly or through the activation of prostasin (28, 43, 45, 53, 54) . Although a number of serine proteases are known to be involved in activation of ENaC, the enzymes involved in physiological regulation of the channel have yet to be identified.
Despite recent attention paid to the regulation of ENaC by serine proteases, tissue kallikrein remains conspicuously absent from the long list of proteases implicated in this process. In 1998, Chraibi et al. (12) found no effect of porcine pancreas kallikrein on X. laevis ENaC; however, the effect of tissue kallikrein on mammalian forms of ENaC has yet to be tested. Tissue kallikrein is a family of 15 serine proteases in humans and 13 in rats (60) . Tissue kallikreins are expressed in a number of different organs including the kidneys, where they are secreted by the principal cells of the connecting tubule into the lumen of the nephron (33) . Although the role of secreted tissue kallikrein in the distal nephron is still in question, it has recently been implicated in Ca 2ϩ transport, HCO 3 Ϫ transport, sodium balance, and adaptation to dietary potassium load (14, 22, 35, 46, 47, 57) . Increased urinary kallikrein secretion is associated with a low-Na diet, aldosterone administration, and a high-K diet, all of which are known to regulate ENaC activity (21, 38) . Such observations led us to speculate that this enzyme might also be involved in the activation of ENaC. Here, we present evidence that urinary tissue kallikrein is able to directly activate amiloride-sensitive current (I Na ) and cleave ␥-ENaC.
METHODS
Oocyte isolation. All procedures using animals were approved by the Institutional Animal Use and Care Committee of Weill Cornell Medical College. Oocytes from X. laevis were harvested and incubated in OR2 solution (mM): 82.5 NaCl, 2.5 KCl, 1 CaCl 2, 1 MgCl2, 1 Na2HPO4, and 5 HEPES at pH 7.4 with 2 mg/ml collagenase type II (Worthington) and 2 mg/ml hyaluronidase type II (Sigma-Aldrich) at room temperature for 60 min with gentle shaking. Oocytes were then washed with OR2 solution and incubated for 1 h at 18°C prior to being injected.
cRNA injection. pSPORT plasmids containing ␣, ␤, and ␥ rat ENaC (rENaC) subunits were linearized with NotI restriction enzyme. X. laevis ENaC (xENaC) plasmids were a generous gift from Dr. Ahmed Chraibi, University of Sherbrooke. The ␣-, ␤-, and ␥-xENaC subunits were in PSDeasy vector. The ␣-and ␥-xENaC subunits were linearized with AflIII and ␤-xENaC was linearized with BglII. Mouse ENaC plasmids were a generous gift from Dr. Thomas Kleyman, University of Pittsburgh. The mouse ENaC (mENaC) subunits were all in pcDNA 3.1 vector. The mouse ␣-and ␤-plasmids were linearized by XhoI and mouse ␥ and ␥RKRK186QQQQ plasmids were linearized by NotI. The linearized plasmids were isolated using a Qiagen QIAquick PCR purification kit. Rat and mouse cRNAs were transcribed using T7 RNA polymerase, and X. laevis cRNAs were transcribed with Sp6 RNA polymerase using mMESSAGE mMACHINE in vitro transcription kits (Ambion). cRNA was dissolved in nuclease-free water and stored at Ϫ80°C. Each oocyte was injected with 4 ng of cRNA from each of the three ENaC subunits. The oocytes were then incubated overnight at 18°C in a low-Na solution (mM): 5 NaCl, 2 KCl, 2 CaCl 2, 1 MgCl2, and 105 NMDG at pH 7.4 to promote expression.
Electrophysiology. Oocytes were perfused with high-Na solution (mM): 110 NaCl, 2 KCl, 2 CaCl 2, 1 MgCl2, and 5 HEPES at pH 7.4. Whole-cell currents were measured using the two-electrode voltage clamp (OC-275, Warner Instrument) with the ITC-16 interface (Instrutech) running Pulse software (Heka Elektronik). Pipettes were made from hematocrit capillary tubes using a threestep vertical pipette puller (David Kopf Instruments) and backfilled with 3 M KCl. Pipettes had resistances of 0.5-3 M⍀. Steady-state current-voltage curves were generated using a pulse protocol of 15 pulses of 50 ms each separated by 10 mV starting at Ϫ80 and ending at ϩ60 mV while holding at the resting membrane voltage between pulses. Steady-state current readings at Ϫ60 mV were analyzed.
Proteases. Porcine pancreas kallikrein (PPK) and trypsin from bovine pancreas were purchased from Sigma-Aldrich. PPK had an activity of 12 esterase units (EU)/mg. One EU will hydrolyze 1.0 mol of N␣-benzoyl-L-arginine ethyl ester (BAEE) to N␣-benzoyl-L-arginine and ethanol per minute at pH 8.7 and 25°C. Trypsin from bovine pancreas had an activity of 13,816 BAEE units/mg. One BAEE unit will produce a ⌬A 253 of 0.001/min at pH 7.6 and 25°C. Rat tissue kallikrein (RTK) was purified from urine using an ammonium-sulfate precipitation followed by a DEAE-cellulose column (see Ref. 11 for complete protocol).
In vitro kallikrein-like and trypsin activity assay. The chromogenic substrate S-2266 (DiaPharma Group) was used to assay kallikreinlike activity in vitro. Tris buffer (200 mM) at pH 8.2 (500 l), a sample solution (400 l), and a substrate solution (100 l) were incubated at 37°C for 30 min. A spectrophotometer (Thermo Spectronic He␥ios) was used to measure the change in absorbance at 405 nm. The kallikrein-like activity was calculated from the equation: kallikrein-like activity (nkat/ml) ϭ 159·⌬Absorbance. Trypsin activity was assayed using the chromogenic substrate S-2222 (DiaPharma Group). Tris/calcium buffer [50 mM Tris and 20 mM CaCl 2 at pH 8.2] (800 l), a sample solution (100 l), and a substrate solution (100 l) were incubated at 37°C for 30 min. The change in absorbance was measured at 405 nm. The trypsin activity was calculated from the following equation: trypsin activity (kat/ml) ϭ 17.36·⌬Absorbance.
Measuring tissue kallikrein excretion in rats. Sprague-Dawley rats (150 -300 g) of either gender (Charles River Laboratories, Kingston, NY) were raised free of viral infections. Animals were kept on control diets containing 0.4% NaCl and 1% KCl by weight. They were then fed for 14 days with either a low-Na or high-K synthetic diet (Harlan-Teklad, Madison, WI) containing 0.004% NaCl or 10% KCl by weight, respectively. Rats were weighed and then placed in metabolic cages from 10:00 AM to 12:00 PM to collect urine. Kallikrein-like activity in urine samples was measured using the chromogenic substrate S-2266, as described above.
Purification and reconstitution of rat urine. Urine was collected from rats fed either a low-Na or high-K diet for 7 days. Twentyseven grams of ammonium sulfate was added to 50 ml of urine and stirred for 5 h at 4°C. The solution was centrifuged at 12,000 rpm for 150 min. The pellet was resuspended with 50 ml of low-Na buffer, which was then passed through a 10-kDa centrifugal filter (Millipore). The unfiltered fraction consisting of the urinary proteins was reconstituted in 15 ml of low-Na buffer and stored at Ϫ80°C.
Immunodepletion and Coomassie staining. Ten micrograms of RTK was incubated with deionized water, sheep anti-RTK IgG, or rabbit anti-RTK IgG. The anti-RTK antibodies were added in a 3:1 molar ratio with RTK. Deiononized water was added to maintain equal volumes in all three preparations, which were then gently rocked at room temperature for 1 h. Forty microliters of protein G-Sepharose Beads (Invitrogen) were added to each sample and gently rocked at 4°C for an additional hour. The supernatants from these samples along with a sample of RTK were incubated with 25 l of LDS sample buffer (Invitrogen) and 10 l of Sample Reducing Agent (Invitrogen) for a total volume of 100 l and heated at 80°C for 7 min. The samples were run on a 4 -12% Bis-Tris gel (Invitrogen) and incubated in Coomassie blue G (Sigma) stain for 10 min at room temperature and destained with solution containing 10% acetic acid and 20% methanol until bands were resolved.
Oocyte biotinylation. Oocytes injected with the ␣, ␤, and ␥ rat or mouse ENaC subunits and incubated overnight in low-Na solution were transferred to low-Na PBS (mM): 95 KCl and 5 NaH2PO4 at pH 8.0. Twenty to twenty-five oocytes were gently rocked for 10 min at room temperature without proteases, with 10 g/ml RTK, or with 3 g/ml trypsin. Wild-type or mutant (RKRK186QQQQ) ␥-mENaC was incubated with or without 10 g/ml RTK. EZ-Link Sulfo-NHS-SS-Biotin (0.5 mg/ml; Pierce) was added, and the oocytes were again rocked gently at 4°C for 30 min. The biotin labeling was then quenched with low-Na TBS (in mM): 80 KCl and 20 Tris at pH 8.0 for 30 min at 4°C. The oocytes were washed twice more with TBS. They were then lysed with repeated pi-petting in 200 l of lysis buffer: 100 mM NaCl, 50 mM Tris, 5 mM EDTA, 1% Triton X-100, 1 g/ml leupeptin, and 10 g/ml PMSF at pH 7.4. The lysate was centrifuged for 10 min at 10,000 g, and the supernatant was retrieved and stored. For whole-cell lysate samples, 20 l of the supernatant was added to 25 l of LDS sample buffer (Invitrogen) and 45 l of H 2O in 1.5-ml Eppendorf centrifuge tubes. For the avidin pulldown, 80 l of supernatant was incubated with 75 l of NeutrAvidin Agarose Resin (Pierce) and 200 l of lysis buffer in 1.5-ml Eppendorf centrifuge tubes overnight at 4°C while gently shaken. The agarose resin was then washed once with lysis buffer, twice with high-Na lysis buffer (500 mM NaCl, 50 mM Tris, 5 mM EDTA, 0.1% Triton X-100, 1 g/ml leupeptin, 10 g/ml PMSF at pH 7.4), and twice with no-salt lysis buffer (10 mM Tris, 1 g/ml leupeptin, 10 g/m; PMSF at pH 7.4). The whole-cell lysate tubes were heated for 5 min at 95°C after 10 l of Sample Reducing Agent was added. The avidin pulldown tubes were heated for 10 min at 80°C after 25 l of LDS sample buffer, 20 l of lysis buffer, and 10 l of Sample Reducing Agent were added to the tubes. The samples were resolved by SDS-PAGE on 4 -12% Bis-Tris gels. For immunoblotting, the proteins were transferred electrophoretically to polyvinylidene difluoride membranes. After blocking with BSA, membranes were incubated overnight at 4°C with polyclonal antibodies raised against the C terminus of the ␥-subunit of rENaC at 1:1,000 dilution. Anti-rabbit IgG conjugated with alkaline phosphatase was used as a secondary antibody. Bound antibody was visualized on autoradiography film (Biomax ML, Kodak) using a chemiluminescence substrate (Western Breeze, Invitrogen).
Statistics. Statistical significance was assessed by unpaired Student t-tests.
RESULTS
To further investigate the time course for induction of urinary kallikrein activity, rats were fed control diets for 7 days and then switched to either a low-Na or a high-K diet for 14 days. The low-Na diet increased excretion of tissue kallikrein-like activity from 5.5 to 18.8·10 Ϫ3 nkat/(100 g/min) 14 days after the low-Na diet was initiated ( Figure 1A ). The high-K diet increased excretion of tissue kallikrein-like activity from 11.2 to 23.0·10 Ϫ3 nkat/(100 g/min) 14 days after the high-K diet was initiated (Fig. 1B) . Low-Na and high-K diets substantially increased kallikrein-like activity in the urine starting on day 5 and maintained elevated levels up to day 14. These diets are known to also upregulate ENaC activity to increase Na ϩ reabsorption and K ϩ secretion. The coinciding time courses of ENaC activation with a low-Na diet found in another study (42) and tissue kallikrein excretion in response to a low-Na or high-K diet in this study suggest a potential role for tissue kallikrein in regulating ENaC activity.
To examine the ability of urinary proteases to activate ENaC, we used an ammonium sulfate precipitation to extract rat urinary proteins. rENaC-expressing oocytes were preincubated in low-Na buffer for 10 min with or without purified urinary proteins. Oocytes treated with urinary proteins had a 2.5-fold greater mean amiloride-sensitive current (I Na ) as measured by two-electrode voltage clamp (TEVC) in high-Na buffer ( Fig. 2A) . To determine whether this activation of I Na was due to proteolytic activity, we tested the ability of aprotinin to abrogate the activation. No effect of urinary proteins was observed in the presence of this universal serine protease inhibitor (Fig. 2B) , suggesting that serine proteases in reconstituted urinary proteins are responsible for the activation of ENaC seen in Fig. 2A .
We hypothesized that tissue kallikrein is at least one component of rat urine responsible for ENaC activation. To test this directly, we initially studied the effect of a commercial kallikrein extract from porcine pancreas (PPK; SigmaAldrich) on ENaC. Based on data presented in the APPENDIX, we showed PPK and trypsin activated rENaC currents. However, soybean trypsin inhibitor (SBTI) inhibited the Fig. 1 . Low-Na and high-K diets increase tissue kallikrein excretion in rat urine. A: kallikrein-like activity in the urine of rats fed a control diet and following 2, 5, 9, and 14 days on a low-Na diet. Activity was measured with a kallikrein substrate and was normalized to rat body weight and urine collection time. Kallikrein-like activity in the urine increased from 5.53·10
Ϫ3 to 18.8·10 Ϫ3 nkat/(100 g/min) after 14 days on a low-Na diet (P ϭ 0.0006). B: kallikrein-like activity in the urine of rats fed a control diet and after 2, 5, 9, and 14 days on a high-K diet. Kallikrein-like activity in the urine increased from 1.12·10
Ϫ2 to 2.30·10 Ϫ2 nkat/(100 g/min) after 14 days on a high-K diet (P ϭ 0.006). Values are means Ϯ SE for 4 animals in each condition.
activation of ENaC by PPK, but not its kallikrein-like activity, as assayed by a chromogenic substrate. In contrast, the less specific aprotinin was able to inhibit both ENaC activation and kallikrein-like activity of PPK (Fig. A1) . As SBTI does not inhibit urinary kallikreins (11), we concluded ENaC activation by PPK might have been due to contaminant proteases. Coomassie staining indicated a large number of contaminating proteins in the PPK (Fig. A2) . This suggests either that the kallikrein activity in the PPK extract was too low to activate ENaC or that rENaC is not cleaved by porcine tissue kallikrein. We next tested a highly purified tissue kallikrein from rat urine (RTK) for its ability to activate ENaC. Figure 3A is a representative trace showing RTK activation of I Na . As summarized in Fig. 3B , RTK increased ENaC currents 2.8-fold and this activation persisted in the presence of 5 g/ml SBTI (3.1-fold). Trypsin had a greater effect on ENaC activation (6.8-fold) in the same batch of oocytes; however, in the presence of SBTI, time-dependent increases in current (1.5-fold) were not significantly different from those in control solution (1.7-fold) (Fig. 3B) . The kallikreinlike and trypsin activities of RTK were tested using the S-2266 and S-2222 chromogenic substrates, respectively. RTK (0.1 g/ml) had a kallikrein-like activity that persisted in the presence of 10 g/ml SBTI but was inhibited by 20 KIU/ml aprotinin (Fig. 3C) . RTK also had minimal trypsin activity that was sensitive to 10 g/ml SBTI and 20 KIU/ml aprotinin, further suggesting a lack of contaminant serine proteases in this preparation (Fig. 3D) . RTK activation of ENaC and its kallikrein-like activity were both SBTI insensitive (Fig. 3B) , indicating that the kallikrein-like activity of RTK is capable of activating ENaC.
We then asked whether RTK could cleave ␥-ENaC. rENaCexpressing oocytes were separated into three groups and incubated for 10 min in control buffer, 10 g/ml RTK, or 3 g/ml trypsin before biotin labeling and isolation of cellsurface proteins. A Western blot of whole-cell lysates probed with rabbit anti-␥ ENaC antibody showed no difference among the three groups in the abundance of full length or cleaved ␥-ENaC. The cell-surface fractions of the three groups had no detectable full-length ␥-subunits; however, there was a decrease of ϳ4 kDa in the apparent molecular mass of the cleaved bands in oocytes exposed to RTK or trypsin compared with control oocytes in two independent Western blots (Fig. 4A ). This suggests that RTK and trypsin further cleaved channels on the cell surface that were already partially processed by intracellular proteases.
The RTK sample was found to be much purer than commercial tissue kallikrein samples (Fig. A2) but still showed additional bands on the Coomassie stain that could be either RTK degradation products or contaminants (Figs. 4B and A2). To demonstrate that RTK and not other contaminants is responsible for cleaving ␥-ENaC, we immunodepleted RTK from the samples and then tested their ability to cleave ␥-ENaC. Two sets of polyclonal anti-RTK IgG antibodies were generated, one in rabbit and the other in sheep (32) . With a Coomassie stain, the sheep anti-RTK light chains (ϳ27 kDa) as well as RTK (ϳ32 kDa) (Fig. 4B) can be seen even after incubation with protein G-Sepharose beads, suggesting an ineffective immunodepletion. This sample cleaved ␥-ENaC similarly to the control RTK sample, further suggesting an ineffective immunodepletion (data not shown). However, rabbit anti-RTK effectively removed RTK and anti-RTK light chains from the preparation (Fig.  4B) . ENaC-expressing oocytes were then incubated with no enzyme, control RTK preparation, or RTK immunodepleted with rabbit anti-RTK. Cleaved ␥-ENaC had the same apparent molecular mass for oocytes incubated with no enzyme or Fig. 2 . Reconstituted rat urinary proteins can activate epithelial Na channel (ENaC) currents through protease activity. A: amiloride-sensitive Na current (INa) was recorded in high-Na buffer for oocytes incubated for 10 min in control low-Na buffer (light gray, n ϭ 27) or low-Na buffer with reconstituted rat urinary proteins (dark gray, n ϭ 25). Oocytes incubated with reconstituted rat urinary proteins had a 2.5-fold increase in INa (P ϭ 0.0001) compared with controls. Values are means Ϯ SE. *Statistical difference from control. B: INa in oocytes incubated in control low-Na buffer (light gray bar, n ϭ 6) was not significantly different from those with 100 KIU/ml aprotinin (dark gray bar, P ϭ 0.66, n ϭ 7) or with reconstituted rat urinary proteinsϩ100 KIU/ml aprotinin (black bar, P ϭ 0.82, n ϭ 6). Values are means Ϯ SE.
RTK immunodepleted with rabbit anti-RTK, while oocytes exposed to the control RTK preparation had a ϳ4-kDa decrease in apparent molecular mass of cleaved ␥-ENaC (Fig. 4C ). This suggests that RTK is the protein responsible for the cleavage of ␥-ENaC.
A previous study by Chraibi et al. (12) found no effect of tissue kallikrein on ENaC activity. In that study, a kallikrein extract from porcine pancreas (Calbiochem) was tested on xENaC. Sequences of Xenopus, rat, and human ␥-ENaC were analyzed for differences in residues proposed to be involved in proteolytic cleavage. In the tract of four adjacent basic residues proposed to serve as the furin cleavage sites (39), ␥-xENaC has a serine at the second position in place of a lysine found in rat and human ␥-ENaC (R135-R138) (Fig. 5A) . However, the canonical cleavage site for furin is R-X-R/K-R (38) , and thus furin cleavage of ␥-xENaC should not be affected by the serine substitution. The basic residues (R177-K180) are proposed to serve as the prostasin cleavage sites in human and rat ␥-ENaC (52). However, ␥-xENaC lacks the third basic residue in the proposed prostasin cleavage sequence and other basic residues (K168, K170, and R172) shown to be important in cleavage by Oocytes expressing rENaC were incubated in 110 mM Na ϩ for 2 min. RTK (10 g/ml; squares) or no enzyme (triangles) was added to the bath for 14 min followed by 10 M amiloride to determine amiloride sensitivity. B: SBTI (5 g/ml) abolished the increase in INa in response to 3 g/ml trypsin (P ϭ 0.049) but not to 10 g/ml RTK (P ϭ 0.65). Values are means Ϯ SE for 6 oocytes in each condition. C: kallikrein substrate assay measuring kallikrein-like activity in vitro. Aprotinin (20 KIU/ml) but not SBTI (10 g/ml) inhibited the kallikrein-like activity of RTK. Values are means Ϯ SE; n ϭ 4 for each condition. *Statistical difference from enzyme alone. D: trypsin substrate assay measuring trypsin enzymatic activity in vitro. RTK (10 g/ml) had a small amount of trypsin activity that was inhibited by aprotinin (20 KIU/ml) and SBTI (10 g/ml). Values are means Ϯ SE; n ϭ 4 for each condition. *Statistical difference from enzyme alone.
other serine proteases (44) (Fig. 5A) . We tested the ability of PPK, RTK, and trypsin to activate xENaC. PPK and trypsin increased ENaC currents in xENaC-expressing oocytes 8.7-and 10.5-fold, respectively. RTK increased ENaC currents only 2.1-fold, which was not significantly different from the time-dependent effect of the control solution (1.4-fold increase) (Fig. 5B) . The minimal effect of RTK on activation of xENaC compared with rat ENaC suggests a potential role for the basic residues R177-K180 in the processing of rat and, presumably, human ␥-ENaC by RTK.
We investigated the role of the proposed prostasin cleavage site in ENaC activation by RTK by comparing wild-type and a quadruple mutant (RKRK186QQQQ) ␥-mENaC (Fig. 6A) . RTK activated wild-type mENaC (2.6-fold) compared with a time control (0.9-fold). However, this activation was completely abolished with mutant (RKRK186QQQQ) ␥-mENaC (1.04-fold) compared with time control (1.07-fold) (Fig. 6B) . We then asked whether RTK could cleave mutant (RKRK186QQQQ) ␥-mENaC. Wild-type and mutant (RKRK186QQQQ) ␥-mENaC-expressing oocytes were incubated for 10 min in either control buffer or 10 g/ml RTK. RTK application to wild-type mENaC led to approximately a 4-kDa decrease in the apparent molecular mass of cleaved ␥-ENaC bands at the cell surface while there was no change in the apparent molecular mass of the (RKRK186QQQQ) mutant (Fig. 6C) . Thus the RKRK motif is essential for tissue kallikrein activation of ␥-ENaC and is the likely site of cleavage for this enzyme, as well as for prostasin.
DISCUSSION
The first evidence of tissue kallikrein in urine came in 1909 when Abelous and Bardier (1) noticed that human urine contained a hypotension-inducing agent then named urohypotensine, later characterized as tissue kallikrein. As early as 1934, a correlation between low urinary kallikrein and hypertension in humans was observed (15) . This was later confirmed in humans as well as rats (36, 37) . In humans, race was found to impact urinary kallikrein excretion. Normotensive blacks have lower urinary kallikrein excretion than normotensive whites, and this is thought to predispose blacks to developing hypertension (24, 30) . Differences in urinary kallikrein excretion and subsequent kinin generation have also been hypothesized to be a cause of salt-sensitive hypertension. Studies using Brown Norway rats, with an inactivating mutation in kininogens, and B2 receptor knockout mice suggest defective kinin activation of B2 receptors as a cause of salt-sensitive hypertension (4, Fig. 5 . Xenopus laevis ENaC (xENaC) is minimally activated by RTK. A: sequence alignment of rat (light gray), human (light gray), and X. laevis (dark gray) ␥-ENaC reveals differences in the residues of the proposed furin (134 -137 in rat) and prostasin (178 -181 in rat) cleavage sites as well as other basic residues thought to play a role in cleavage by serine proteases. B: PPK (P ϭ 0.01, n ϭ 4) and trypsin (P Ͻ 0.0001, n ϭ 3) increased INa in oocytes expressing xENaC (n ϭ 5). The effect of RTK on INa (n ϭ 7) was not significantly different from time controls (n ϭ 5, P ϭ 0.18). Fig. 6 . RTK activates ENaC through the prostasin cleavage site. A: sequence alignment of rat (light gray), mouse (light gray), and mutant mouse (RKRK186QQQQ) ␥-mENaC (␥RKRK/Q4; dark gray) shows the prostasin (181-184 in mouse) cleavage site that is mutated to glutamines. B: RTK (P ϭ 0.03, n ϭ 5) increased INa in oocytes expressing wild-type mENaC compared with time controls (n ϭ 5) but had no effect on mutant (RKRK186QQQQ) ␥-mENaC (P ϭ 0.82, n ϭ 5) compared with time controls (n ϭ 5). C: Western blot of ␥-ENaC from oocytes expressing wild-type or ␥RKRK/Q4 mENaC and incubated for 10 min in either control buffer or 10 g/ml RTK. RTK lowered the apparent molecular mass of cleaved ␥-ENaC at the cell surface by ϳ4 kDa for wild-type mENaC but not ␥RKRK/Q4 mENaC, consistent with ␥-ENaC cleavage by RTK at this site. 34 ). Urinary kallikrein excretion in salt-sensitive hypertensive humans was less than in salt-resistant hypertensive subjects (17, 18) .
The correlation between low urinary kallikrein and hypertension has generated the concept that low urinary kallikrein promotes hypertension or conversely high urinary kallikrein can decrease blood pressure. Tissue kallikrein has been shown to regulate a number of different Na ϩ -reabsorbing pathways through local production of kinins such as bradykinin. Recent studies suggest that amiloride-insensitive, electroneutral sodium transport through the Na ϩ -dependent chloride-bicarbonate exchanger SLC4A8 serves as an important Na ϩ reabsorption pathway in the cortical collecting duct (CCD) (29) . In previous experiments by Tomita et al. (55, 56) , a similar electroneutral Na ϩ reabsorption pathway was inhibited by bradykinin and may serve as a sodium-reabsorbing pathway regulated by tissue kallikrein. However, the importance of this amiloride-insensitive sodium reabsorption pathway in the CCD has been debated, and others have found that the dominant mechanism of sodium reabsorption in the CCD is electrogenic and amiloride sensitive (50) . A recent study showed bradykinin can decrease the P o of ENaC in mice connecting tubule and CCD (61), suggesting bradykinin generated by tissue kallikrein can downregulate sodium reabsorption through both Na ϩ -reabsorbing pathways in the connecting tubule and CCD. However, it is also possible that the causality is reversed and that hypertension results in low urinary kallikrein excretion. Conditions of volume depletion (e.g., a low-Na diet) as well as aldosterone infusion have been shown to increase urinary kallikrein excretion (5, 16, 21, 38) . This suggests that blood pressure serves as a cue for regulating urinary kallikrein excretion, possibly as a homeostatic mechanism in which urinary kallikrein can help replete blood volume and increase blood pressure by activating sodium reabsorption in the distal nephron.
The direct effect of tissue kallikreins on ENaC-expressing epithelia was first examined by Lewis and Alles (31) , who showed that the protease decreased I Na in rabbit urinary bladder, presumably through degradation of Na channels. Later, Chraibi et al. (12) found tissue kallikrein had no effect on I Na in xENaC-expressing oocytes. Recently, Picard et al. (46) suggested that tissue kallikrein plays a role in activating ENaC through proteolytic processing. They showed that kallikrein could cleave ␥-ENaC in a cell-free system, but channel activity was not assessed.
We provide the first direct evidence that tissue kallikrein is able to activate ENaC currents. Using a combination of purified RTK and a set of serine protease inhibitors, we demonstrated ENaC activation by tissue kallikrein. Immunodepleting RTK from the sample using anti-RTK antibodies prevented ␥-ENaC cleavage, further verifying RTK's ability to cleave ␥-ENaC and activate the channel.
In addition, we propose that activation of ENaC by RTK is due to direct cleavage of ␥-ENaC as opposed to a product of a proteolytic cascade as suggested for low concentrations of plasmin (54) . SBTI was not able to inhibit the activation of ENaC by RTK, indicating that it is not activating another SBTI-sensitive serine protease (i.e., prostasin) that is responsible for ENaC activation.
Cell-surface cleaved ␥-ENaC consisted of two clear bands in ENaC-expressing oocytes. The first band at ϳ70 kDa and the second at ϳ65 kDa are noted as the intermediately and maximally cleaved bands, respectively. RTK and trypsin both shifted cleaved ␥-ENaC toward the maximally cleaved band and seemed to produce a third band at ϳ60 kDa, which may be a physiologically relevant cleaved product or a degradation product of cleavage. This finding is consistent with the theory proposed by Bruns et al. (6) suggesting that ␥-ENaC must be cleaved twice, once intracellularly by furin and once by an extracellular protease, to be fully activated.
At the biochemical level, Picard et al. (46) provided evidence for a role for tissue kallikrein in ␥-ENaC processing. They showed that tissue kallikrein knockout mice have decreased ␥-ENaC cleavage compared with wild-type mice on a control-Na diet. However, after 3 days of Na restriction or aldosterone infusion there was a similar ratio of uncleaved to cleaved ␥-ENaC. Examination of these Western blots indicates a qualitative difference in the cleaved fraction of ␥-ENaC; knockout mice seem to have more of the intermediately cleaved fraction of ␥-ENaC compared with wild-type mice that have more of the maximally cleaved fraction of ␥-ENaC, suggesting a second kallikrein-dependent processing step. This is consistent with the effects of direct application of proteases to oocytes that we report here (Fig. 3C ). This qualitative effect suggests that tissue kallikrein could physiologically regulate ENaC activity during Na restriction and aldosterone infusion by further processing partially cleaved channels through a second cleavage to a more active form.
We found decreased ENaC activation by RTK in xENaC compared with rENaC. The proposed prostasin cleavage site has a key difference in ␥-xENaC compared with human and rat ␥-ENaC (Fig. 5A) . The basic residues from 177 to 180 (RKRK) in human and rat ␥-ENaC have the consensus sequence R/K-H/R/K-basic residue-R/K for prostasin cleavage (52), while ␥-xENaC has the sequence KRTR, lacking the basic residue at the third site. This difference in the proposed prostasin cleavage site of ␥-xENaC may explain why Chraibi et al. (12) found no activation of xENaC with their kallikrein extract and why we found a minimal effect of RTK on xENaC. We therefore decided to specifically investigate the role of the proposed prostasin cleavage site on RTK activation of ENaC. We showed that the increase in I Na and cleavage of ␥-ENaC at the cell surface by RTK on wild-type mENaC is completely abolished in the mutant (RKRK186QQQQ) ␥-mENaC (Fig. 6, B and C) . This suggests that the putative prostasin cleavage site is necessary for cleavage by RTK.
In summary, our current study provides direct evidence for tissue kallikrein activation of ENaC and sodium reabsorption. In addition, we signify the prostasin cleavage site as playing a key role in ENaC activation by tissue kallikrein. We propose tissue kallikrein has the potential to be a physiologically relevant protease modulating ENaC activity, as the same signals that upregulate ENaC activity are found to upregulate tissue kallikrein secretion into the distal nephron. Fig. A2 . Rat tissue kallikrein (RTK) is of higher purity than PPK. Coomassie staining of different kallikrein and trypsin preparations is used to assay purity of samples. Recombinant human tissue kallikrein (a gift from Dr. Michael Blaber, Florida State University) produced a clear single band. PPK showed numerous proteins, many of which corresponded to those of the bovine pancreas trypsin sample. The faint band at ϳ32 kDa is consistent with porcine tissue kallikrein. RTK had two prominent bands at 32-33 kDa, consistent with rat tissue kallikrein.
